Phase 2 Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Aug 15, 2024 - P2 | N=43 | Not yet recruiting | Sponsor: Sutro Biopharma, Inc.
Metastases • New P2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|